Skip to main content

Case details

Case Number: UPC_APP_4423/2023

  • Patent number:
    EP4025568 - RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME,
    EP4025572 - HETEROCYCLIC RIP1 KINASE INHIBITORS,
    EP4126864 - RIP1K INHIBITORS,
    EP4025575 - RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME,
    EP3788044 - RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME,
    EP4055021 - HETEROCYCLIC RIP1 INHIBITORY COMPOUNDS,
    EP4025574 - RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME,
    EP3788045 - RIP1 INHIBITORY COMPOUNDS AND METHODS FOR MAKING AND USING THE SAME

  • Proceeding type: Application

  • Action/Application: Opt-out

  • Applicants:
    Eli Lilly and company Represented by Deborah Butler

  • Court Division: appealInstance - seat - Luxembourg

  • Date of Formal receipt: 2023-04-04 19:31:22